Тяжелый острый респираторный синдром

1. Anand K., Ziebuhr J., Wadhwani P. et al. Coronavirus main proteinase (3Clpro) structure: basis for design of anti-SARS drugs. Science 2003; 300: 1763-1767.

2. Cinatl J., Morgensterm В., Bauer G. et al. Glycyrrhizin, an active component of liquorice roots, and replication of SARSassociated coronavirus. Lancet 2003; 361: 2045-2046.

3. Cyranoski D., Abbot A. Virus detectives seek source of SARS in China's wild animals. Nature 2003; 423: 467.

4. Drosten Ch., Gunther S., Preiser W. et al. Identification of novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 2003; 348: 1967-1976.

5. Kontoyiannis D.P., Pasqualini R. Aminopeptidase N inhibitors and SARS. Lancet 2003; 361: 1558.

6. Ksiazek T.G., Erdman D., Goldsmith C.S. et al. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 2003; 348 (20): 1953-1966.

7. Lee N., Hui D., Wu A. et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. Ibid. 1986-1994.

8. Marra M .A., Jones S.J., Astell C.R. et al. The genome sequence of the SARS-associated coronavirus. Science 2003; 300’ 1399-1404.

9. Oba Y. The use of corticosteroids in SARS. N. Engl. J. Med 2003; 348 (20): 2934-2936.

10. Poutanen S.M ., Low D.E., Henry B. et al. Identification of severe acute respiratory syndrome in Canada. Ibid. 1995-2005.

11. Reilley B., Van Herp M ., Sermand D., Dentico N. SARS and Carlo Urbani. Ibid. 1951-1953.

12. Rota P.A., Oberste M.S., Monroe S.S. et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003; 300: 1394-1398.

13. Tsang K.W., Ho P.L., Ooi G.C. et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N. Engl J Med. 2003; 348 (20): 1977-1985.

14. Wu E.B., Sung J.J.Y. Haemorrahagic-fever-like changes and normal chest radiograph in doctor with SARS. Lancet 2003; 361: 1520-1522.